Vaxcyte, Inc.

NasdaqGS:PCVX 주식 보고서

시가총액: US$11.0b

Vaxcyte 관리

관리 기준 확인 4/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Grant Pickering

최고 경영자

US$12.1m

총 보상

CEO 급여 비율5.3%
CEO 임기11yrs
CEO 소유권0.5%
경영진 평균 재임 기간4.5yrs
이사회 평균 재임 기간5.5yrs

최근 관리 업데이트

Recent updates

Vaxcyte: Stunning PCV Data Readout Suggests Vaccine Maker Is A Strong Buy

Sep 06

We're Not Very Worried About Vaxcyte's (NASDAQ:PCVX) Cash Burn Rate

Aug 24
We're Not Very Worried About Vaxcyte's (NASDAQ:PCVX) Cash Burn Rate

Vaxcyte (NASDAQ:PCVX) Has Debt But No Earnings; Should You Worry?

May 10
Vaxcyte (NASDAQ:PCVX) Has Debt But No Earnings; Should You Worry?

Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans

Dec 27
Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely

Sep 12
We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Vaxcyte's (NASDAQ:PCVX) Cash Burn Situation

May 30
Here's Why We're Not Too Worried About Vaxcyte's (NASDAQ:PCVX) Cash Burn Situation

We Think Vaxcyte (NASDAQ:PCVX) Can Afford To Drive Business Growth

Dec 22
We Think Vaxcyte (NASDAQ:PCVX) Can Afford To Drive Business Growth

Vaxcyte appoints new CBO, CMO

Oct 11

Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans

Aug 05
Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans

Vaxcyte completes enrollment in phase 2 portion of study of pneumonia vaccine candidate

Jul 12

CEO 보상 분석

Grant Pickering 의 보수는 Vaxcyte 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

-US$508m

Jun 30 2024n/an/a

-US$497m

Mar 31 2024n/an/a

-US$437m

Dec 31 2023US$12mUS$640k

-US$402m

Sep 30 2023n/an/a

-US$300m

Jun 30 2023n/an/a

-US$265m

Mar 31 2023n/an/a

-US$245m

Dec 31 2022US$14mUS$601k

-US$223m

Sep 30 2022n/an/a

-US$174m

Jun 30 2022n/an/a

-US$143m

Mar 31 2022n/an/a

-US$118m

Dec 31 2021US$5mUS$575k

-US$100m

Sep 30 2021n/an/a

-US$92m

Jun 30 2021n/an/a

-US$87m

Mar 31 2021n/an/a

-US$83m

Dec 31 2020US$3mUS$481k

-US$89m

Sep 30 2020n/an/a

-US$83m

Jun 30 2020n/an/a

-US$73m

Mar 31 2020n/an/a

-US$64m

Dec 31 2019US$596kUS$426k

-US$50m

보상 대 시장: Grant 의 총 보상 ($USD 12.14M )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 12.66M ).

보상과 수익: Grant 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Grant Pickering (56 yo)

11yrs

테뉴어

US$12,135,683

보상

Mr. Grant E. Pickering, M.B.A., is Co-Founder of Vaxcyte, Inc. since 2013 and has been its Chief Executive Officer and Director since November 2013 and served as its President since November 2013 until Dec...

리더십 팀

이름위치테뉴어보상소유권
Grant Pickering
Co-Founder11yrsUS$12.14m0.53%
$ 58.6m
Andrew Guggenhime
President & CFO4.5yrsUS$5.42m0.059%
$ 6.5m
James Wassil
Executive VP & COO4.9yrsUS$5.40m0.14%
$ 15.3m
Mikhail Eydelman
Senior VP2.6yrsUS$3.49m0.0081%
$ 896.1k
Ashish Khanna
Co-Founder11.8yrs데이터 없음데이터 없음
Jeff Fairman
Co-Founder & VP of Researchno data데이터 없음데이터 없음
Elvia Cowan
Senior VP of Finance & Principal Accounting Officer1.8yrs데이터 없음0.0031%
$ 345.4k
Janet Graesser
Senior Vice President of Corporate Communications & Investor Relationsno data데이터 없음데이터 없음
Whitney Jones
Chief People Officerless than a year데이터 없음데이터 없음
Paul Sauer
Senior Vice President of Process Development & Manufacturing8.6yrsUS$2.35m데이터 없음
Harp Dhaliwal
Senior Vice President of Commercial Manufacturing & Supply Chain3yrsUS$1.84m데이터 없음
Sam Iki
Senior Vice President of Project Managementno data데이터 없음데이터 없음

4.5yrs

평균 재임 기간

55yo

평균 연령

경험이 풍부한 관리: PCVX 의 관리팀은 경험 ( 4.5 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Grant Pickering
Co-Founder11yrsUS$12.14m0.53%
$ 58.6m
Annie Drapeau
Independent Director3.2yrsUS$704.22k0.0045%
$ 497.7k
K. Hirth
Independent Director8.2yrsUS$696.72k0.010%
$ 1.1m
Heath Lukatch
Independent Director6.5yrsUS$691.72k0.0045%
$ 497.7k
Halley Gilbert
Independent Director4.6yrsUS$704.22k0.0045%
$ 497.7k
Emmanuel Walter
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Carlos Paya
Independent Chairman of the Board3.1yrsUS$724.22k0.0045%
$ 497.7k
Anthony Ford-Hutchinson
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Jeffrey Almond
Member of Scientific Advisory Board7.8yrs데이터 없음데이터 없음
Teri Loxam
Independent Director3.2yrsUS$704.22k0.0045%
$ 497.7k
Emmanuel Hanon
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
William Hausdorff
Member of Scientific Advisory Boardno data데이터 없음데이터 없음

5.5yrs

평균 재임 기간

57yo

평균 연령

경험이 풍부한 이사회: PCVX 의 이사회는 경험(평균 재직 기간 5.5 년)으로 간주됩니다.